A novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cells

International Journal of Pharmaceutics

Volumn 408, Issue 1-2, 2011, Pages 173-182

  Cai, Lulu ^a   Qiu, Neng ^a   Li, Xia ^a   Luo, Kaili ^a   Chen, Xiang ^a   Yang, Li ^a   He, Gu ^a   Wei, Yuquan ^a   Chen, Lijuan ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b CHENGDU UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Chol PEG2000 COOH polymer; truncated bFGF conjugated micelles paclitaxel; Tumor targeting drug delivery

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CHOLESTEROL; FIBROBLAST GROWTH FACTOR RECEPTOR; MACROGOL; PACLITAXEL; RHODAMINE B;

ARTICLE; CYTOPLASM; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG RELEASE; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; MICELLE; PARTICLE SIZE; PRIORITY JOURNAL; TUMOR CELL;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CYTOPLASM; DRUG CARRIERS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FIBROBLAST GROWTH FACTOR 2; HUMANS; MICE; MICELLES; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; MOLECULAR STRUCTURE; PARTICLE SIZE; PEPTIDE FRAGMENTS; POLYETHYLENE GLYCOLS; PROTEIN BINDING; RECEPTORS, FIBROBLAST GROWTH FACTOR; SOLUBILITY; SURFACE PROPERTIES; SURFACE-ACTIVE AGENTS;

EID: 79953233439     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2011.01.042     Document Type: Article

References (36)

1. Bikram, M., Ahn, C., Chae, S.Y., Lee, M., Yockman, J.W., Kim, S.W., 2004. Biodegradable poly (ethylene glycol)-co-poly (L-lysine)-g-histidine multiblock copolymers for nonviral gene delivery. Macromolecules 37, 1903-1916.
2. Chen, X., Wang, X.H., Wang, Y.S., Yang, L., Hu, J., Xiao, W.J., Fu, A.F., Cai, L.L., Li, X., Ye, X., Liu, Y.L., Wu, W.S., Shao, X.M., Mao, Y.Q., Wei, Y.Q., Chen, L.J., 2010. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide. J. Control. Release 145, 17-25.
3. Dharap, S.S., Wang, Y., Chandna, P., Khandare, J.J., Qiu, B., Gunaseelan, S., Sinko, P.J., Stein, S., Farmanfarmaian, A., Minko, T., 2005. Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc. Natl. Acad. Sci. U.S.A. 102, 12962-12967.
4. Goldman, C.K., Rogers, B.E., Douglas, J.T., Sosnowski, B.A., Ying, W.B., Siegal, G.P., 1997. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor. Cancer Res. 57, 1447-1451. (Pubitemid 27175559)
5. Hamaguchi, T., Matsumura, Y., Suzuki, M., Shimizu, K., Goda, R., Nakamura, I., Nakatomi, I., Yokoyama, M., Kataoka, K., Kakizoe, T., 2005. NK105, a paclitaxel-incorporating micellar nanoparticle formulation, can extend in vivo antitumour activity and reduce the neurotoxicity of paclitaxel. Br. J. Cancer 92, 1240-1246. (Pubitemid 40604398)
6. Harashima, H., Ishida, T., Kamiya, H., Kiwada, H., 2002. Pharmacokinetics of targeting with liposomes. Crit. Rev. Ther. Drug Carrier Syst. 9, 235-275.
7. He, Q.M., Wei, Y.Q., Tian, L., Zhao, X., Su, J.M., Yang, L., Lu, Y., Kan, B., Lou, Y.Y., Huang, M.J., Xiao, F., Liu, J.Y., Hu, B., Luo, F., Jiang, Y., Wen, Y.j., Deng, H.X., Li, J., Niu, T., Yang, J.L., 2003. Inhibition of tumor growth with a vaccine based on xenogeneic homologous fibroblast growth factor receptor-1 in mice. Biol. Chem. 278, 21831-21836.
8. Kerbel, R.S., 2000. Tumor angiogenesis: past, present and the near future. Carcinogenesis 21, 505-515. (Pubitemid 30137936)
9. Kim, T.Y., Kim, D.W., Chung, J.Y., Shin, S.G., Kim, S.C., Heo, D.S., Heo, N.K., Bang, Y.J., 2004. Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies. Clin. Cancer Res. 10, 3708-3716.
10. Kong, H.L., Crystal, R.G., 1998. Gene therapy strategies for tumor antiangiogenesis. J. Natl. Cancer Inst. 90, 273-286.
11. Kwon, G.S., 2003. Polymeric micelles for delivery of poorly water-soluble compounds. Crit. Rev. Ther. Drug Carrier Syst. 20, 357-403.
12. Lasic, D.D., 1992. Mixed micelles in drug delivery. Nature 355, 279-280.
13. Lee, H., Hu, M., Reilly, R.M., Allen, C., 2007. Apoptotic epidermal growth factor (EGF)- conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy. Mol. Pharm. 4, 769-781.
14. Li, D., Yu, H., Huang, H.L., Shen, F.P., Wu, X.Y., Li, J.Z., 2007. FGF receptor-mediated gene delivery using ligands coupled to Polyethylenimine. Biomater. Appl. 22, 163-180.
15. Liu, L.H., Guo, K., Lu, J., Venkatraman, S.S., Luo, D., Ng, K.C., Ling, E.A., Moochhala, S., Yang, Y.Y., 2008. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood brain barrier. Biomaterials 29, 1509-1517.
16. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N., 2004. Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br. J. Cancer 91, 1775-1811.
17. Matsumura, Y., Kataoka, K., 2009. Preclinical and clinical studies of anticancer agentin-corporating polymer micelles. Cancer Sci. 100, 572-579.
18. Moghimi, S.M., Hunter, A.C., Murray, J.C., 2001. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol. Rev. 53, 283-318.
19. Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Setti Guthi, J., Chin, S.F., Sherry, A.D., Boothman, D.A., Gao, J., 2006. Multifunctional polymeric micelles as cancer-targeted, MRI-ultrasensitive drug delivery systems. Nano Lett. 6, 2427-2430.
20. Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., Kataoka, K., 2003. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63, 8977-8983. (Pubitemid 38064079)
21. Otsuka, H., Nagasaki, Y., Kataoka, K., 2003. PEGylated nanoparticles for biological and pharmaceutical applications. Adv. Drug Deliv. Rev. 5, 403-419.
22. Plum, S.M., Holaday, J.W., Ruiz, A., Madsen, J.W., Fogler, W.E., Fortier, A.H., 2000. Administration of a liposomal FGF-2 peptide vaccine leads to abrogation of FGF-2-mediated angiogenesis and tumor development. Vaccine 19, 1294-1303. (Pubitemid 32008298)
23. Rancourt, C., Rogers, B.E., Sosnowski, B.A., Wang, M.H., Piche, A., Pierce, G.F., 1998. Basic fibroblast growth factor enhancement of adenovirus-mediated delivery of the herpes simplex virus thymidine kinase gene results in augmented therapeutic benefit in a murine model of ovarian cancer. Clin. Cancer Res. 4, 2455-2461.
24. Rosa, P.A.J., Azevedo, A.M., Ferreira, I.F., Vries, J.de, Korporaal, R., Verhoef, H.J., Visser, T.J., 2007. J. Chromatogr. 1162, 103-113.
25. Shchors, K., Evan, G., 2007. Tumor angiogenesis: cause or consequence of cancer? Cancer Res. 67, 7059-7061.
26. Shuai, X., Ai, H., Nasongkla, N., Kim, S., Gao, J., 2004. Micellar carriers based on block copolymers of poly (epsilon-caprolactone) and poly (ethylene glycol) for doxorubicin delivery. J. Control. Release 98, 415-426. (Pubitemid 39093952)
27. Sosnowski, B.A., Gonzalez, A.M., Chandler, L.A., Buechler, Y.J., Pierce, G.F., Baird, A., 1996. Targeting DNA to cells with basic fibroblast growth factor (FGF2). J. Biol. Chem. 271, 33647-33653. (Pubitemid 27010184)
28. Sutton, D., Nasongk, N., Blanco, E., Gao, J., 2007. Functionalized micellar systems for cancer targeted drug delivery. Pharm. Res. 24, 1029-1046.
29. Terada, T., Mizobata, M., Kawakami, S., Yabe, Y., Yamashita, F., Hashida, M., 2006. Basic fibroblast growth factor-binding peptide as a novel targeting ligand of drug carrier to tumor cells. J. Drug Target 14, 536-545. (Pubitemid 44592887)
30. Terada, T., Mizobata, M., Kawakami, S., Yamashita, F., Hashida, M., 2007. Optimization of tumor-selective targeting by basic fibroblast growth factor-binding peptide grafted PEGylated liposomes. J. Control. Release 119, 262-270. (Pubitemid 46770875)
31. Toncheva, V., Schacht, E., Ng, S.Y., Barr, J., Heller, J., 2003. Use of block copolymers of poly (ortho esters) and poly (ethylene glycol) micellar carriers as potential tumour targeting systems. J. Drug Target. 11, 345-353. (Pubitemid 38081338)
32. Torchilin, V.P., 2001. Structure and design of polymeric surfactant-based drug delivery systems. J. Control. Release 73, 137-172. (Pubitemid 32544594)
33. Torchilin, P.V., Lukyanov, N.A., Gao, Z.G., Brigitte, P.S., 2003. Immunomicelles: Targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. U.S.A. 100, 6039-6044.
34. Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y., Kataoka, K., 2001. Long-circulating poly (ethylene glycol)-poly (D, L-lactide) block copolymer micelles with modulated surface charge. J. Control. Release 77, 27-38. (Pubitemid 33022613)
35. Zamboni, W.C., 2005. Liposomal, nanoparticle, and conjugated formulations of anticancer agents. Clin. Cancer Res. 11, 8230-8234.
36. Zelphati, O., Wang, Y., Kitada, S., Reed, J.C., Felgner, P.L., Corbeil, J., 2001. Intracellular delivery of proteins with a new lipid-mediated delivery system. J. Biol. Chem. 276, 35103-35110.